Tag Archives: FDA

DIGITAL HEALTH: A P&P RETROSPECTIVE

What better way to envision the road ahead than by taking a look back at all the industry milestones, predictions, and opinions shared over the past few years on Pixels & Pills? So while we work...
Posted in Digital Health | Tagged , , , , , , | Leave a comment

DTC is Just Around the Corner

As we prepare for this year's DTC conference in washington, we wanted to share one of our favorite interviews from last year's conference. Here's former Governor and Presidential candidate Howard...
Posted in Social Media | Tagged , , , | Leave a comment

Are You There Facebook? It’s Me, Pharma.

By DJ Edgerton (@wiltonbound) Who controls the conversation about your brand in the social media space? You? The consumer? The FDA? Those are the usual suspects that come up when we have those...
Posted in Social Media | Tagged , , , , , , , | 1 Comment

A New Approach to FDA Guidelines

By Sven Larsen (@svenplarsen) Frustrated with the wait for FDA social media guidelines? Trying to make sense of the Sunshine Act? You're not alone. In fact, those concerns are shared by just...
Posted in Social Media | Tagged , , , , , , , , | Leave a comment

Got Questions About Compliance?

By Sven Larsen (@svenplarsen) We received a welcome surprise in our Pixels and Pills inbox this week, the first monthly newsletter from Dr. Darshan Kulkarni. We've interviewed Darshan before and...
Posted in Social Media | Tagged , | 1 Comment

Conversation: Darshan Kulkarni on the FDA Draft Guidance

Last week Pixels & Pills' editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , | Leave a comment

In Light of FDA Draft Guidance? Keep Going

by Briana Campbell (@MsMatchGirl) By now, youve all had time to review the FDAs draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical...
Posted in Social Media | Tagged , , , , , , , , , , , , , | 8 Comments

Can Pharma Harness Social Media for Product Research and Development?

by DJ Edgerton (@wiltonbound) The question seems almost nonsensical at first your Twitter followers may be really outstanding people, but theyre not organic chemists or researchers. And your...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Shoot First, Apologize Later: Why Pharma Needs to Proceed without Social Media Guidelines

by DJ Edgerton (@wiltonbound) Like Tom Petty sang, the waiting is the hardest part. But is it necessary for pharma to continue holding out for social media guidelines before implementing digital...
Posted in Social Media | Tagged , , , , , , , | 4 Comments

Adapt or Die! Why Pharma Needs To Get In Line

by Sven Larsen #Adaptordie is an apt hashtag to sum up the teachings of digital-media punditBrian Solis. Its also an apt hashtag to describe the current state of affairs in the pharmaceutical...
Posted in Social Media | Tagged , , , , , , , , , , , | 4 Comments

Social Media, Pharma and Politics

by DJ Edgerton (@wiltonbound) How much of a role does social media play in influencing policymakers? And how much of a role can or should marketing play in crafting those messages for...
Posted in Social Media | Tagged , , , , , , , , , , | 1 Comment

Revisited: Russ Ward on FDA Guidelines For Social Media

As we keep talking (and talking and talking) about and waiting (and waiting and waiting) for FDA Guidelines for social media usage, we thought it would be fun to visit this video, from nearly two...
Posted in Social Media | Tagged , , , , | Leave a comment